Definitive Contract 75N93019C00068
Award Date 9/30/19
Potential Completion Date 9/29/24
Potential Value $5.4M
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Seattle, WA 98101, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to the Benaroya Research Institute at Virginia Mason (BRI), a non-profit biomedical research institute. The $4,987,029.99 cost-no-fee contract is for a "LARGE SCALE ANTIBODY & T CELL DISCOVERY PROGRAM, HIGH THROUGHPUT SCREENING ANTIBODY AND T CELL EPITOPES". The contract has an ultimate completion date of September 30, 2009. BRI has...
- This is a Cost No Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Benaroya Research Institute at Virginia Mason (BRI), a non-profit biomedical research organization. The $5,332,500.00 contract is for biomedical research services, with a period of performance from September 28, 2007 through September 27, 2013. BRI has previously provided research services to federal agencies like the Department of Veterans Affairs and the National Institutes...
- This federal contract award, valued at $5,403,317.00, was granted to the University of Washington (UW) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract is for the project "PROTECTIVE T CELL EPITOPES AND IMMUNE RECEPTORS FOR SEXUALLY TRANSMITTED INFECTIONS" and does not have a set-aside designation. The original solicitation indicates...
- This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS), to the University of Washington (UW) for a project titled "LARGE SCALE T CELL EPITOPE DISCOVERY". The contract has a ceiling value of $5,476,460.78 and a completion date of September 29, 2025. It is a cost-no-fee contract, meaning the contractor is reimbursed for allowable costs without any additional fee....
- This is a $4,495,633 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the La Jolla Institute for Immunology, a non-profit research institute, for "LARGE SCALE T CELL EPITOPE DISCOVERY". The contract has no set-aside designation. The contract involves T cell and B cell immunology research, including epitope identification, vaccine development, and studies on the immune mechanisms underlying infectious diseases, allergies, autoimmune...
- This $32,903,521 federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Seattle Children's Hospital to provide scientific support for research on the structural biology of infectious diseases. The contract is not set aside for any specific business category. The contract involves multiple subcontractors, including the University of Washington, Dartmouth College, and the University of Kansas, who will provide services such as protein structure...
- This is a $5,820,000 cost-no-fee, definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) to the University of Massachusetts Medical School (UMass Medical) to support research on T cell immune epitopes associated with infectious diseases, autoimmune diseases, commensal organisms, and transplant rejection. The contract, which runs through September 29, 2029, is an outgrowth of a pre-solicitation notice NIAID...
- This $5,635,564.60 cost-reimbursable definitive contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance), a non-profit medical research organization. The contract supports targeted clinical research to address select viral infections. There was no set-aside designation. Under the contract, Fred Hutchinson Cancer Center is...
- This is a $5,455,392.00 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the La Jolla Institute for Immunology, a non-profit research institute. The contract is for the identification and validation of epitopes (immune system targets) that are conserved across viral pathogen families with pandemic potential. The research will focus on infectious diseases, autoimmune diseases, and transplant rejection. No set-aside was used for this award. The...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Washington School of Medicine. The $23,012,457.00 firm-fixed-price contract is for specialized biomedical services and laboratory testing to support federal healthcare and research initiatives. The School of Medicine, which is a part of the University of Washington, has extensive expertise in clinical pathology,...